Baciewicz F A, Melvin W S, Basilius D, Davis J T
Department of Surgery, Medical College of Ohio, Toledo.
Thorac Cardiovasc Surg. 1989 Dec;37(6):369-71. doi: 10.1055/s-2007-1020355.
Patients with Down's syndrome represent a significant subset of patients with congenital heart disease. Fifty-five patients with Down's syndrome have undergone surgical treatment for congenital heart disease at our institution in the past decade. Twenty-six had atrioventricular canal, 11 had ventricular septal defect, 7 had secundum atrial septal defect, 7 had tetralogy of Fallot, 3 had primum atrial septal defect and 1 patient had double outlet right ventricle. The thirty day mortality following operative intervention was 16.4%. Mortality was highest for tetralogy of Fallot followed by atrioventricular canal and ventricular septal defect. Long term mortality for all lesions was 27.3% over our follow-up period which averaged 33 months. Thirty day mortality compared similarly to previous reports of surgically treated Down's syndrome patients. When compared to our patients without Down's syndrome, the Down's population did not exhibit an increased risk for surgical treatment of congenital heart disease.
唐氏综合征患者是先天性心脏病患者中的一个重要亚组。在过去十年中,我们机构有55例唐氏综合征患者接受了先天性心脏病的外科治疗。26例患有房室通道,11例患有室间隔缺损,7例患有继发孔型房间隔缺损,7例患有法洛四联症,3例患有原发孔型房间隔缺损,1例患有右心室双出口。手术干预后的30天死亡率为16.4%。法洛四联症的死亡率最高,其次是房室通道和室间隔缺损。在我们平均为期33个月的随访期内,所有病变的长期死亡率为27.3%。30天死亡率与先前关于接受外科治疗的唐氏综合征患者的报告相似。与我们的非唐氏综合征患者相比,唐氏综合征患者群体在先天性心脏病手术治疗中并未表现出更高的风险。